IMBDX

Service

Early detection of cancer.

Healthcare Checkup

CancerFind

간편한 검사

1. Simple

Analysis of cancer-related genes
through blood

Through a simple blood draw, key genes related to various cancer types of solid cancers (including gastric, lung, colon, breast, liver, pancreatic, ovarian and uterine cancer, as well as rare cancers such as melanoma and sarcoma) can be tested for somatic mutations.

정확한 분석

2. Accurate

In-depth analysis using the latest
AlphaLiquid® bioinformatics analysis

CancerFind delivers fast and accurate results based on IMBdx’s robustly validated, machine-learning enabled and patented
AlphaLiquid® bioinformatics pipeline for genomic data analytics.

Recommended for

  • 1. Suspected cancer risk diagnosis (e.g., increase in cancer markers)
  • 2. Cancer survivors (e.g., during follow-up after cancer treatment)
  • 3. High-risk groups (e.g., family history of cancer)

CancerFind Test Process

  • 1.혈액채취

    Blood Sampling

    Easy collection of blood

    30mL of blood is sampled for the CancerFind test.
    The blood is stored in dedicated cfDNA tubes.

  • 2. 유전자 분석

    Genetic Analysis

    Genetic mutation analysis using AlphaLiquid’s latest bioinformatics pipeline

    cfDNA in the blood is extracted and amplified to run Next Generation Sequencing and subsequent AlphaLiquid® analysis to detect mutations.

  • 3. 결과 보고서

    Clinical Report

    Results delivered in 3 weeks

    The results are delivered in a report which includes information on genetic mutations, its characteristics, and descriptions of target genes.

Features of CancerFind

Diversified Analysis of Shift Patterns

Detects all major types of genomic alternations including Single nucleotide variants (SNVs), Insertions & Deletions (Indels), Copy Number Alterations (CNAs), Fusions, as well as key genomic signatures such as Microsatellite Instability (MSI), Tumor Mutation Burden (TMB), Loss of Heterozygosity (LOH)

  • Advantages to Tissue Biopsy

    It can be difficult or sometimes impossible to collect a sufficient sample for a tissue biopsy, depending on the size and location of the tumor.

    · CancerFind test conducted through a convenient blood draw.
  • Advantages to other blood-based cancer marker tests

    Blood cancer markers (e.g., CEA, CA-19-9, PSA) can be increased without there actually being cancer, resulting in high false positives and poor accuracy.

    · CancerFind directly analyzes cfDNA derived from tumor cells which enables accurate testing for various genomic alternations and signatures.
  • Advantages to other blood-based cancer marker tests

    Blood genetic tests are for used for hereditary cancer-related (germline) mutations, and their accuracy and specificity can be compromised as they are limited in detecting somatic mutations.

    · CancerFind is based on the clinically validated AlphaLiquid® 100 panel which consists of carefully selected, high-frequency cancer-related genes applicable to most types of solid cancers to produce more specific and sensitive test results.